MannKind is trading at $3.00 (-12.53%) in pre-market, with no specific catalyst identified for the October 29 move.

  • MannKind’s newsroom latest listed release is dated October 14.
  • The Nasdaq Composite is down 1.44% in the supplied market context; this does not establish the cause of MannKind’s decline.
  • Available evidence points to an unclear catalyst rather than a confirmed company-specific event.